Header Logo

Connection

BARBARA JANE O'BRIEN to Mefloquine

Back to Details
This is a "connection" page, showing publications BARBARA JANE O'BRIEN has written about Mefloquine.
BARBARA JANE O'BRIEN
Connection Strength
0.161
Mefloquine
  1. Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma. Cancer. 2019 02 01; 125(3):424-433.
    View in: PubMed
    Score: 0.161
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.